Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.649450
Title: The aetiology of systemic inflammation and its link with prognosis in gastro-oesophageal cancer
Author: Deans, D. A. C.
Awarding Body: University of Edinburgh
Current Institution: University of Edinburgh
Date of Award: 2008
Availability of Full Text:
Full text unavailable from EThOS.
Please contact the current institution’s library for further details.
Abstract:
The aims of this thesis were to describe the genesis, mediators and clinical sequelae of systemic inflammation in patients with gastro-oesophageal cancer. A consecutive series of 220 patients with gastric or oesophageal cancer were studied. Systemic inflammation (CRP>10 mg/l) was present in 43% of patients with gastro-oesophageal cancer. Serum acute phase protein concentrations (especially CRP), but not serum cytokine concentrations, were robust measures of systemic inflammatory activity. However, concentrations of pro-inflammatory cytokines within tumour tissue were significantly elevated and were linked with markers of systemic inflammation. IL-1β in particular was over-expressed in tumour tissue and may be a key determinant of systemic inflammation in patients with gastro-oesophageal malignancy. A chronic inflammatory cell infiltrate into the tumour tissue was present in 75% of tumours and was also linked with markers of systemic inflammation. Tumour cells or host immune cells or a combination of the two may be the main source of these mediators. The presence of systemic inflammation was also influenced by host cytokine genotype. Other potential tumour-derived mediators, such as PIF and PTHrP, may also play a (minor) role in the generation of systemic inflammation. CRP concentrations were identified as the best marker of prognosis and the magnitude of serum CRP concentrations were negatively liked with survival duration. 83% of patients had lost weight at the time of diagnosis and within 3 months this had increased to 92%. Increasing weight loss was positively associated with serum markers of systemic inflammation. Weight loss among patients with gastro-oesophageal cancer was not accounted for entirely by reduced food intake or mechanical obstruction secondary to the tumour. Alternatively, the presence of systemic inflammation contributed to nutritional decline (estimate of effect 34%). Weight loss was associated with adverse outcome and cachexia may be an aetiological factor involved in the link between systemic inflammation and adverse prognosis. Systemic inflammation, weight loss, performance status, and stage of disease were the main determinants of outcome in patients with gastro-oesophageal cancer. These factors were used to devise a novel model to improve prognostic accuracy. These studies identify systemic inflammation as both an important prognostic indicator and a potential therapeutic target.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (M.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.649450  DOI: Not available
Share: